LAVAL, Quebec, Feb. 27, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces fourth quarter financial results for 2013.
Fourth Quarter 2013
-- 2013 Fourth Quarter Total Revenue $2.1 billion; an increase of 109% over the prior year
Help employers find you! Check out all the jobs and post your resume.
